Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen Images

Generic Name: insulin degludec

This medication has been identified as Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen. It is supplied by Novo Nordisk.

Tresiba is used in the treatment of Type 2 Diabetes; Diabetes, Type 1; Diabetes Mellitus and belongs to the drug class insulin. Risk cannot be ruled out during pregnancy. Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Tresiba

Generic Name

insulin degludec

Strength

100 units/mL (U-100) single-patient-use FlexTouch Pen

Availability

Prescription only

Drug Class

Insulin

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Novo Nordisk

National Drug Code (NDC)

00169-2660

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer